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1,25-Dihydroxyvitamin D3 modulates the
phenotype and function of Monocyte
derived dendritic cells in cattle
Yolanda Corripio-Miyar1 , Richard J. Mellanby2, Katy Morrison1 and Tom N. McNeilly1*
Abstract
Background: The active form of the vitamin D3, 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) has been shown to have
major effects not only on physiological processes but also on the regulation of the immune system of vertebrates.
Dendritic cells are specialised antigen presenting cells which are in charge of the initiation of T-cell dependant
immune responses and as such are key regulators of responses towards pathogens. In this study we set out to
evaluate the effects of 1,25-(OH)2D3 on the phenotype of cattle monocyte-derived dendritic cells (MoDCs) and how
the conditioning with this vitamin affects the function of these myeloid cells.
Results: MoDCs were generated from CD14+ monocytes with bovine IL-4 and GM-CSF with or without 1,25-(OH)2D3
supplementation for 10 days. Vitamin D conditioned MoDCs showed a reduced expression of co-stimulatory and
antigen presenting molecules, as well as a reduced capability of endocytose ovalbumin. Furthermore, the capacity of
MoDCs to induce proliferation in an allogeneic mixed leukocyte reaction was abolished when MoDCs were generated
in presence of 1,25-(OH)2D3. LPS induced maturation of 1,25-(OH)2D3conditioned MoDCs resulted in lower secretion of
IL-12 and higher IL-10 than that observed in MoDCs.
Conclusions: The typical immunotolerant phenotype observed in cattle DCs after exposure to 1,25-(OH)2D3 has a
significant effect on the functionality of these immune cells, inhibiting the T-cell stimulatory capacity of MoDCs. This
could have profound implications on how the bovine immune system deals with pathogens, particularly in diseases
such as tuberculosis or paratuberculosis.
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Background
Dendritic cells (DCs) are professional antigen-presenting
cells (APC) which act as a bridge between innate and
adaptive immune responses. DCs patrol the periphery of
the immune system in an immature state where they use
their unique specialised function to capture and process
antigens. Once they receive this maturation signal, they
migrate to lymphoid organs and, by secreting cytokines
and chemokines, expressing co-stimulatory molecules in
their surface and presenting antigens to T cells, are able to
initiate a cascade of immune responses [1]. However, DCs
not only activate primary immune responses against foreign
antigens, they also differentiate non-self from self-antigens
and by inducing immunological tolerance in T cells, are
able to control autoimmune responses which have the po-
tential to damage the host. The depletion of DCs in animal
models breaks self-tolerance of CD4+ T cells and is associ-
ated with the onset of fatal autoimmune diseases [2].
Given that the induction of immunotolerance could be
used to prevent undesirable immune responses for indi-
viduals with autoimmune diseases or undergoing trans-
plantations, these cells are being investigated for their
potential use as therapeutic targets [3–5]. However,
studying the function of DCs in different species can be
hampered by the difficulties which arise during the isola-
tion and identification of these cells. Not only are there
various DC phenotypes depending on the tissue where
they are found, but they also express different markers in
different species [6–9]. However, monocytes can be differ-
entiated into dendritic cells (MoDCs) by the addition of
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IL-4 and GM-CSF [10, 11]. As their function and pheno-
type are typical of immature DCs, MoDCs are a good sub-
stitute to freshly isolated DCs and can be used as in vitro
models of innate immune responses.
Recent studies have revealed that the active form of the
vitamin D3, 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3),
can play an important role in calcium and bone homeosta-
sis and the regulation of the immune system [12–18]. The
immune modulatory functions of vitamin D include the
regulation of genes involved in host immune defense such
as antimicrobial peptides [15], the prevention of the onset
of autoimmune diseases models [19], or inhibition of the
production of inflammatory cytokines in response to
inflammatory or infectious stimuli [20]. However, as an
immunomodulator, this hormone can also affect the func-
tion and development of monocytes and dendritic cells.
As professional antigen presenting cells, DCs require the
production of IL-12 to drive naïve T cell to a Th1 pheno-
type and recent studies have shown a reduction in se-
cretion of IL-12 by DCs which have been treated with
high doses of 1,25-(OH)2D3, leading to an overall reduced
functionality [16, 21]. Furthermore, 1,25-(OH)2D3 is able
to down-regulate the expression of MHC-II and co-
stimulatory molecules in DCs as well as modulate their
cytokine production.
The majority of studies investigating the effects of
1,25-(OH)2D3 on DCs and the immune system have
been carried out in humans [5, 16] or mice [22, 23], with
only a few studies carried out in veterinary species. In
poultry, Vitamin D has been shown to inhibit prolifera-
tion and IFN-γ production by lymphocytes [14], while
the addition of 1,25-(OH)2D3 to chicken macrophages
up-regulates the production of nitric oxide by 5-fold,
consequently improving the phagocytic nature of these
cells [24]. In ruminants, the majority of the work investi-
gating the effects of vitamin D has been focused on
nutritional aspects [25], although the role of vitamin D
in reproductive fitness [26] and infectious diseases such
as bovine tuberculosis [27] and mastitis [28] has also
been investigated. In Mycobacterium bovis infected cattle
it has been shown that 1,25-(OH)2D3 can inhibit M. bovis-
specific proliferation of CD4+ and γδ T cells [29, 30]. Fur-
thermore, activation of the vitamin D pathway using a
monoclonal antibody to the vitamin D receptor has been
shown to suppress M. bovis-specific proliferation and
interferon gamma (IFN-γ) production of peripheral blood
mononuclear cells [27]. In this latter study the suppressive
effects were associated with a down-regulation of CD80
expression, suggesting that activation of the vitamin D
pathway was associated with a deficiency in antigen pre-
senting cell (APC) function. However, in contrast to work
in mice and humans there have been no studies specific-
ally addressing the effects of vitamin D on ruminant APC
phenotype and functionality.
In this study we investigate the immunomodulatory
effects of 1,25-(OH)2D3 on cattle DCs. We generated
Vitamin D conditioned MoDCs by differentiating bovine
CD14 monocytes with IL-4 and GM-CSF in the presence
of 1,25-(OH)2D3 (VitD-MoDCs). We then examined the
phenotype and functionality of these VitD-MoDCs and
compared to that of standard MoDCs.
Methods
Animals
Healthy 6-months old Holstein-Friesian and Ayrshire calves
were purchased from two Scottish commercial dairy farms
and maintained at Moredun Research Institute (MRI), UK.
All animals were kept off pasture for the duration of the ex-
periments. All experiments were approved by the Ethics
Committee at MRI and were performed to Home Office
Guidelines under Project Licence (PPL 60/3854).
Isolation of bovine PBMC and in vitro generation of
Monocyte derived Dendritc cells (MoDCs)
Blood was collected aseptically into 350 ml blood bags con-
taining 45 ml of Citrate phosphate dextrose-adenine 1
(CPDA-1) stabiliser (Sarstedt, Germany). PBMC were iso-
lated as previously described [31] using density gradient
centrifugation by layering whole blood diluted with phos-
phate buffered saline (PBS) onto Ficoll-Paque™ PLUS (GE
Healthcare Life Sciences). Buffy coat was collected and
washed three times with PBS and re-suspended in MACS
Buffer [PBS + 0.5% foetal bovine serum (FBS, from USA
supplied by Sigma-Aldrich, UK)]. CD14 monocytes were
positively selected by incubation of PBMC with CD14
MicroBeads (clone TÜK4, Miltenyi Biotech, Germany) in
cold MACS buffer for 15 min at 4 °C. Cell-microbead com-
plex were washed twice, resuspended in 3 ml of MACS buf-
fer and purified over an LS column as per manufacturer’s
instructions. Purified CD14 monocytes were washed to
eliminate any residual microbeads and resuspended in
tissue culture medium (RPMI-1640 medium) supple-
mented with 10% FBS and 50 μM 2-mercaptoethanol,
2 mM L-glutamine, 100 U/ml Penicillin and 100 μg/ml
Streptomycin (all from Sigma-Aldrich, UK). Enrichment
purity was consistently above 95% as assessed by flow
cytometry. Monocyte derived dendritic cells (MoDC) were
generated in the presence of bovine GM-CSF and IL-4 (Bo-
vine Dendritic Cell Growth kit, Bio-Rad) for 10 days as pre-
viously described [13, 31] with some modifications.
Briefly, purified cattle monocytes were seeded in 6-well
plates at a concentration of 106cells/ml. Cells were
cultured in the presence of 50 μl/ml of Bovine DC
Growth Kit and 10 nM 1,25-(OH)2D3for Vitamin D3 con-
ditioned MoDCs (VitD-MoDCs), or 50 μl/ml of Bovine
DC Growth Kit only for MoDCs. Fresh medium, cytokines
and 1,25-(OH)2D3 where applicable were replenished on
day 3 and 6 of culture. Cells were harvested on day 10.
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Phenotype of MoDCs and VitD-MoDCs
Single colour flow cytometric analysis was carried out to
phenotype bovine MoDCs and VitD conditioned MoDCs.
After 10 days of culture as detailed above, cells were
harvested and following a 10 min blocking step with 20%
normal goat serum (NGS, Bio-Rad) in PBS, incubated
with the following un-conjugated monoclonal anti-
bodies: CD1b (CC14, Bio-Rad), CD80 (IL-A159, Bio-Rad),
CD86 (IL-A190, Bio-Rad) and MHCII-DR (CC108, Bio-
Rad) at pre-optimised concentrations for 20 min. Cells
were then washed twice with FACS buffer (PBS +
5%FBS + 0.05%NaN3) and further incubated for 20 min
with a secondary anti-mouse IgG mAb conjugated to
Alexa-Fluor® 647 (Invitrogen, Life Technologies, US).
After two washes, cells were resuspended in the dead
cell stain Sytox Blue (Invitrogen, Life Technologies, US)
and immediately a minimum of 10,000 events were
acquired using a MACSQuant® Analyzer 10 (Miltenyi
Biotech, Germany). Post acquisition gating, including
dead cell and doublet cell discrimination, and analysis
were carried out using FlowJo vX for Windows 7. Phase
contrast images of MoDC and VitD-MoDCs were cap-
tured using an Axiovert 200 M inverted microscope
(Carl Zeiss Ltd., UK).
Endocytosis by MoDCs and VitD-MoDCs
One of the main roles of DCs is the sampling of their en-
vironment for antigens through endocytosis. Consequently,
to assess the effect of 1,25-(OH)2D3 enrichment on endo-
cytosis, we used DQ-Ovalbumin (DQ-OVA, Molecular
Probes, Life Technologies, US), a self-quenched conjugate
which exhibits bright green fluorescence upon proteolytic
degradation yielding a low background signal. Hence, 105
MoDCs or VitD conditioned MoDCs were incubated with
10 μg/ml of DQ-OVA or medium only for 1 h at 37 °C.
After incubation, cells were washed 3 times with FACS
buffer and resuspended in Sytox Blue (ThermoFisher) prior
to flow cytometry analysis as detailed above.
Mixed leukocyte reaction
In order to define the capability of VitD conditioned
MoDCs to stimulate an alloreactive mixed leukocyte reac-
tion (allo-MLR) an experiment was set up using two ani-
mals from different breeds which showed high proliferation
in preliminary MLRs. PBMC obtained from an Ayrshire
calf were used as responder cells, whilst MoDCs generated
from a Holstein-Friesian calf were used as the allogeneic
stimulators. MoDCs and VitD-MoDCs were generated
for 10 days as described earlier and stimulated with or
without LPS for 24 h. Cells were harvested and irradi-
ated (60Gy) to ensure that detected proliferation was
derived only from PBMCs. Irradiated MoDCs were
then resuspended in complete medium with 10% FBS
at a concentration of 105cells/ml. Responder PBMC
(105 per well) were incubated with irradiated MoDCs/
VitDMoDCs at the following ratios, 1:10, 1:20, 1:100,
1:200, 1:400 and 1:1000. Reactions were set up in
quadruplicate in U-well microtitre plates in a total
volume of 200 μl. Controls consisted of responder
PBMC or irradiated stimulator cells in medium alone
or with 5 μg/ml of Concanavalin A (ConA, Sigma-
Aldrich). Cells were incubated at 37 °C for 4 days after
which 50 μl of medium was collected from each repli-
cate/treatment and replenished with fresh complete
medium containing methyl-3H thymidine (0.5 μCi per
well; Amersham Biosciences UK Ltd., Chalfont St.
Giles, Buckinghamshire). Proliferation was measured
by the incorporation of methyl-3H thymidine during
the final 18 h of culture as previously described [32].
Data are presented as the corrected counts per minute
(ccpm) averaged over 3 min.
Cytokine secretion after LPS stimulation
MoDCs and 1,25(OH)2D3 conditioned MoDCs were har-
vested on day 10 and incubated with 1 μg/ml of LPS
(0111:B4, Sigma UK) or medium only for 24 h. After stimu-
lation supernatants were collected to analyse cytokine se-
cretion induced by LPS. Capture ELISAs were performed
to examine the secretion of IL-1β (Anti-Bovine IL-1β poly-
clonal capture and detection antibodies, BioRad), IL-10
(clones CC318 and CC320b, BioRad) and IL-12 (clones
CC301 and CC326b, BioRad). Standard curves were
constructed using recombinant bovine IL-1β (BioRad) and
transfected COS-7 cells supernatants for IL-10 [33] or IL-
12 [34]. All incubations were carried out at room
temperature unless stated and washing steps were per-
formed 6 times with 350 μl washing buffer (PBS + 0.05%
Tween 20) using a Thermo Scientific Wellwash™ Versa
(ThermoFisher). Briefly, high-binding capacity ELISA plates
(Immunolon™ 2HB 96-well microtiter plates, Thermo-
Fisher) plates were coated with capture antibodies at pre-
optimised concentrations and incubated over night at 4 °C.
Plates were then washed and blocked for 1 h with PBS+ 3%
Bovine Serum Albumin (BSA, Sigma). Following a further
washing step, 50 μl of supernatants or standards were
added in duplicate for 1 h. Plates were then washed and
detection antibodies added for 1 h. This was followed by
washing and addition of Streptavidin-HRP (Sigma) for
45 min. After the final washing step, 50 μl of SureBlue
TMB substrate (Insight Biotechnology, London, UK) was
added and the reaction was stopped by the addition of
H2SO4. Absorbance values were read at O.D. 450 nm. All
values were blanked corrected and concentrations
determined from standard curve.
Statistical analysis
Statistical analyses were performed using the non-
parametric test Kruskal-Wallis and a Dunns multiple
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comparison post hoc test in the case of not normally dis-
tributed data or One-Way ANOVA and a Tukey post hoc
test when data were normally distributed. All analyses
were carried out within the Minitab version 17 statistical
package, with p < 0.05 considered significant.
Results
1,25(OH)2D3 conditioning influences the phenotype and
endocytic capabilities of bovine MoDCs
Monocytes were incubated with boIL-4 and boGM-CSF
alone or with 1,25-(OH)2D3 for a period of 10 days. All
cultures were set up with the same starting monocyte
number, but interestingly, the supplementation of MoDCs
with 1,25-(OH)2D3 during differentiation clearly improved
the survival of the MoDCs. Typically, after the 10 day cul-
ture period, around 4.6 times more cells were recovered
from the 1,25-(OH)2D3 conditioned cultures than those
differentiated with IL-4 + GM-CSF only (cell recovery
expressed as percentage of starting population: 6–30% in
MoDCs vs 25–100% in VitD-MoDCs; Fig. 1), showing the
need for supplementation with 1,25-(OH)2D3 throughout
the differentiation process. In order to determine if
1,25(OH)2D3 conditioning affected the phenotype and
function of MoDCs, we initially investigated the expres-
sion of antigen presenting and co-stimulatory molecules
which are typically up-regulated in CD14 monocytes cul-
tured with GM-CSF and IL-4 alone. As expected, MoDCs
expressed high levels of CD1b, CD80, CD86 and MHC-II
(Fig. 2). However, when MoDCs were supplemented with
1,25(OH)2D3 during differentiation, the expression of all
four markers remained consistently lower than in MoDCs.
Although this reduced MFI was observed for all four
markers, only CD1b was significantly down-regulated in
VitD-MoDCs when compared to MoDCs (p = 0.016).
Immature DCs have the ability to efficiently uptake anti-
gens by endocytosis, consequently in order to assess the
endocytic capacity of the VitD-MoDCs, we investigated the
uptake of the model antigen ovalbumin (OVA), a protein
taken up by clathrin-coated pits in dendritic cells [35].
1,25(OH)2D3 conditioned MoDCs and MoDCs and were
incubated with DQ-OVA for 1 h, after which cells were
harvested and analysed by flow cytometry. A signifi-
cantly lower level of internalisation and processing of
OVA was observed in VitD-MoDCs when compared
MoDCs (Fig. 3, p = 0.025).
Impaired ability of 1,25(OH)2D3 conditioned MoDC to
induce lymphocyte proliferation
We then tested the influence of 1,25(OH)2D3 conditioning
in the ability of MoDCs to induce lymphocyte proliferation
in an allo-MLR following LPS maturation. Unstimulated
MoDCs were able to significantly increase spontaneous
proliferation of PBMC at ratios of 1:10, 1:20 and 1:100 of
MoDCs to PBMC (p = 0.009, p = 0.001, p = 0.021 re-
spectively, Fig. 4). In contrast, the incorporation of
thymidine by PBMC incubated with unstimulated MoDCs
conditioned with 1,25(OH)2D3 remained below the level of
spontaneous proliferation of PBMC only controls (dashed
line in Fig. 4), even at high stimulator:responder ratios.
This difference was enhanced up to 7-fold when both cell
types were matured with LPS prior to setting up the MLR.
While LPS stimulated MoDCs were able to generate a high
level of proliferation in lymphocytes with as little as 103
MoDCs per 105 PBMC, LPS-stimulated VitD-MoDCs
were unable to induce a convincing PBMC proliferative re-
sponse at any of the MoDC:PBMC ratios tested (LPS VitD
conditioned MoDCs vs LPS MoDCS; at 1:10, p < 0.001, at
1:20, p < 0.001, and at 1:100, p = 0.021).
1,25(OH)2D3 enhances LPS driven IL-10 production by
MoDCs
As professional APCs, the main function of DCs is the
activation of naive T cells. In order to do so, DCs process
antigens and present them on their surface to the T cells.
Furthermore, the secretion of cytokines by MoDCs is
able to influence the phenotype of the T cells they
activate [36]. Consequently, we analysed the LPS in-
duced cytokine secretion by MoDCs differentiated in the
a b
Fig. 1 Cattle CD14 + ve monocytes differentiated in the presence of 1,25 (OH)2D3. MoDCs were generated as detailed in Material and Methods
with or without 1,25(OH)2D3. All treatments were seeded at a 10
6cells/ml and supplemented with boIL-4, boGM-CSF with or without 10 nM of
1,25(OH)2D3 on day 1, day 3 and day 6 of culture. Cells were harvested on day 10. Phase contrast images of MoDCs with (a) or without (b) 1,25
(OH)2D3 depicts an increased proportion of cells in wells containing cells differentiated in the presence of 1,25(OH)2D3
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presence or absence of 1,25(OH)2D3 after a stimulation
period of 24 h. There was no significant difference in the
secretion of any of the cytokines between resting
MoDCs and VitD-MoDCs (Fig. 5). However, after a 24 h
stimulation with LPS, the secretion of IL-1β, IL-10 and
IL-12 was significantly upregulated both by MoDCs or
VitD-MoDCs (Fig. 5a, b, c; all p = 0.009). This LPS
driven cytokine secretion was consistently higher in
VitD-MoDCs for all three cytokines (all p = 0.0122)
when compared to MoDCs. When expressed as a
fold increase in cytokine release relative to the un-
stimulated controls, the fold increase in IL-1β secre-
tion by 1,25-(OH)2D3 conditioned MoDCs was 21.4,
while the fold increase for MoDCs was only 6.5 (Fig. 5e,
p<0.0001). The opposite could be seen for IL-12 secretion,
where the MoDCs produced significantly more cyto-
kine than its vitamin D conditioned counterpart
(Fig. 5e, p=0.01). No significant differences were ob-
served in the fold increase in IL-10 secretion between
MoDCs and VitD-MoDCs (Fig. 5e). However, when
expressed as a ratio of IL-10/IL-12, MoDCs cells se-
creted higher levels of IL-12 in comparison to IL-10
after LPS stimulation compared to the 1,25-(OH)2D3
conditioned MoDCs (Fig. 5d; p < 0.0001).
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Fig. 2 Phenotype of cattle MoDCs differentiated in the presence or absence of 1,25 (OH)2D3. Phenotype of MoDCs or 1,25 (OH)2D3
conditioned MoDCS derived from cattle CD14 + ve monocytes was analysed by flow cytometry. MoDCs were single stained with primary
mAbs to CD1b, CD80, CD86 or MHC-II DR and then stained with Alexa Fluor 647 IgG secondary antibody. Live, single gated cells were
assessed for expression of these markers. a Data shown are the average ± the SE of the corrected median fluorescence intensity (MFI) for
MoDCs (black bars) and 1,25 (OH)2D3 conditioned MoDCS (white bars). b Histogram for a representative animal showing the level of
uptake of expression of chosen markers for MoDCs (black histograms) or 1,25 (OH)2D3 conditioned MoDCS (grey histograms). *denotes
statistical significance for p < 0.05
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Fig. 3 The endocytic capabilities of cattle MoDCs are diminished by
conditioning with 1,25(OH)2D3. MoDCs were differentiated from cattle
CD14 monocytes in the absence (black bars) or presence (white bars)
of 1,25(OH)2D3 for 10 days. After harvesting, cells were incubated for
1 h with DQ-OVA and uptake analysed by flow cytometry. Live, single
cells were gated and the MFI of each treatment calculated. The results
shown are average ± SE of two animals representing the DQ MFI for
uptake by MoDCs and 1,25(OH)2D3 conditioned MoDCs. * denotes
statistical significance for p < 0.05
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Fig. 4 MoDCs differentiated in the presence of 1,25(OH)2D3 are not able to induce an allogeneic mixed leukocyte reaction. MoDCs differentiated from
cattle CD14 monocytes in the presence or absence of 1,25(OH)2D3 for 10 days. After harvesting, cells incubated with or without LPS for 24 h. Following
stimulation, cells were irradiated and cultured in quadruplicate at different ratios with 105responder PBMC for 5 days. Responder PBMC and stimulator
MoDCs were incubated in medium only or with ConA (5μg/ml) as controls of proliferation. Proliferation was measured by the incorporation of methyl-3H
thymidine ([3H]TdR; 0.5 μCi per well) for the final 18 h of culture. Data are presented as the corrected counts per minute (ccpm) averaged over 3 min. Data
shown are the representative of two independent experiments with error bars denoting ± SE. Dashed line denotes the spontaneous proliferation of PBMC
with no ConA/stimulator cells. * denotes statistical significance for p < 0.05, ** p value between 0.001 and 0.01 and *** for p < 0.001
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Fig. 5 Cytokine secretion by cattle MoDCs differentiated in the presence or absence of 1,25(OH)2D3. MoDCs differentiated from cattle CD14 + ve
monocytes in the presence or absence of 1,25(OH)2D3 for 10 days. After harvesting, cells incubated with (white bars) or without LPS (black bars)
for 24 h. Following stimulation, secretion of IL-1β (a), IL-12 (b) and IL-10 (c) into culture supernatants were measured by ELISA. Data are expressed
as the concentration of cytokine in picograms (pg) or biological units (BU) per ml of supernatant. (d) Fold increase of cytokine secretion. (e) Ratio
of IL10/IL12 secretion. Results are shown as the mean values with error bars indicating ± SE from four animals. * denotes statistical significance
for p < 0.05, ** p value between 0.001 and 0.01 and *** for p < 0.001
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Discussion
The influence of 1,25-(OH)2D3 on the function of im-
mune cells has been widely discussed, from their effects
on the central nervous system [13], to the modulation of
innate immune responses by macrophages [28], or the
induction of tolerogenic DCs [16, 18, 22]. However, little
information is available on the immunomodulatory ef-
fects of 1,25-(OH)2D3 in ruminants or how they obtain
this hormone from the environment.
When exploring the effect of vitamin D3 at a cellular
level, some studies have focused on its ability to inhibit
mitogen or antigen induced secretion of IFNγ in bovine
lymphocytes [30, 37], while others have shown that
when 1,25-(OH)2D3 is added to bovine monocyte cul-
tures infected with Mycobacterium bovis, NO production
is enhanced and apoptosis of antigen-stimulated cells re-
duced [30]. The production of 1,25-(OH)2D3 by bovine
monocytes has also been reported to modulate iNOS
and RANTES expression in LPS stimulated monocytes
[38]. However, there is currently little evidence regarding
how 1,25-(OH)2D3 affects other key immune cells such
as DCs, which are required to activate naive T cells in
order to trigger an effective immune response.
Here we show the profound effects that are caused by
1,25-(OH)2D3 conditioning during the differentiation of
bovine MoDCs. Bovine MoDCs have a distinct pheno-
type when compared to afferent lymph DCs [35, 39],
they express co-stimulatory molecules such as CD1b
and MHCII at a higher level than CD14 monocytes all
of which are required for antigen presentation. When we
investigated the phenotype of MoDCs differentiated in
the presence or absence of 1,25-(OH)2D3, the expression
of both markers was lower in the 1,25-(OH)2D3 condi-
tioned MoDCs, particularly CD1b. This is in agreement
with work carried out in other mammalian species, such
as human [16, 40] or mice [21], indicating that the pres-
ence of 1,25-(OH)2D3 in the culture medium is able to
hinder the complete differentiation of monocytes into
MoDCs. Reports on the expression of CD86 and CD80
have been more inconsistent. In some cases CD86 was
lowly expressed by VitD-MoDCs and CD80 was un-
affected [16]; in other cases, the expression of both cell
surface markers is lower when MoDCs are differentiated
with 1,25-(OH)2D3 [23]. During the present study the
addition of 1,25-(OH)2D3 from day 0 impeded the same
level of upregulation of CD80 and CD86 seen in
MoDCs, a trend seen for all four markers investigated.
The ability to take up antigens is a crucial biological
function of dendritic cells. When encountering an antigen,
APCs are able to process antigens via the endocytic path-
way and present them to quiescent naive T cells, initiating
a cascade of immune responses [41]. Consequently, in
order to examine if 1,25-(OH)2D3 conditioned MoDCs are
able to endocytose antigens, we investigated the uptake of
OVA by clathrin-coated pits [31, 35]. As in human
[16, 42], bovine 1,25-(OH)2D3 conditioned MoDCs
are functionally impaired for endocytosis, as a signifi-
cantly lower level of internalisation of OVA could be
observed when compared to cells incubated without
vitamin D during the differentiation process.
The key function of DCs, antigen presentation, was
not only affected phenotypically by the supplementation
of MoDCs with 1,25-(OH)2D3, but also functionally as
seen by the suppression of the T-cell stimulatory cap-
acity in 1,25-(OH)2D3 conditioned MoDCs. Five days
after incubation with allogeneic PBMC, MoDCs were
able to induce proliferation with numbers as low as 103
MoDCs per 105 PBMC. However, 1,25-(OH)2D3 condi-
tioned MoDCs were never able to induce a proliferation
higher than background proliferation measured by PBMC
incubated in medium only. When maturation was driven
by stimulation with LPS for a period of 24 h, this T-cell
stimulatory capacity was enhanced in MoDCs while con-
ditioned MoDCs remained lower than the background
proliferation. This correlation between phenotype and T-
cell stimulatory capacity has been seen in other species
[16, 23, 40, 43] and confirms that vitamin D3 also fails to
activate cattle dendritic cells. Upon TLR4 activation, we
also observed a clear up-regulation of IL-12 secretion both
in MoDCs and in 1,25-(OH)2D3 conditioned MoDCs.
However, when investigated further, the fold increase in
IL-12 with MoDCs was double that seen in 1,25-(OH)2D3
conditioned MoDCs, a difference also reflected by the low
IL-10/IL-12 ratio in MoDCs. Vitamin D3 has been shown
to have a negative effect on the production of IL-12
MoDCs after exposure to LPS in human studies [16, 43].
As IL-12 is the main cytokine which drives Th1 differenti-
ation in naive T cells [36], the reduction we observed in
IL-12 secretion by 1,25-(OH)2D3 conditioned MoDCs
after LPS stimulation, suggests that these Vitamin D con-
ditioned cells may induce a reduced Th1 phenotype in the
T cells they activate.
Secretion of IL-10 by DCs has an important role in
immunosuppressive responses and is key to the differen-
tiation of CD4+ type 1 T-regulatory (Tr1) cells [44, 45].
Consistent with other murine and human studies
[16, 22, 23, 43], we demonstrated that 1,25-(OH)2D3
conditioned MoDCs secrete relatively higher levels
of IL-10 and lower of IL-12 than MoDCs. This indi-
cates a clear suppressing action of vitamin D3 on
DC development which is able to drive a typical
immunotolerant phenotype on cattle DCs. The implica-
tions of this on adaptive immune responses in vivo is
unclear, although it is known that co-immunization of
antigens with supplementary vitamin D results in class-
switching of B cells to IgA, suggesting this vitamin can
play an important role in modulating bovine adaptive
immune responses in vivo [46].
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Cattle obtain vitamin D3 from either the diet or from
photoconversion of 7-dehydrocholesterol in the skin fol-
lowing exposure to UV light from sunlight [47]. As com-
mon grassland plants do not contain vitamin D3, skin is
the principle source of this vitamin in grazing cattle [48].
However, in current agricultural systems a significant
proportion of cattle are house under conditions with lit-
tle or no sunlight and therefore dietary supplementation
of vitamin D, usually in the form of vitamin D3, is re-
quired [25, 49]. Supplementation guidelines are available
for cattle which provide daily vitamin D requirements
for different classes and ages of cattle [50]. However,
these recommendations are largely based on levels of
vitamin D required to maintain calcium balance rather
than immune function. As vitamin D acts in an endo-
crine manner for calcium homeostasis, but an intracrine
and paracrine manner for many of the non-calcaemic
functions of vitamin D [51], it is possible that the re-
quirements of vitamin D for calcium homeostasis and
immune function may differ. Consequently current rec-
ommendations for vitamin D supplementation in cattle
may not be sufficient for optimal immune function.
Given the growing body of evidence that vitamin D can
modulate immunity in cattle, future research should
focus on determining the optimum concentrations of
vitamin D3 required for immune function, and how vari-
ables associated with vitamin D3 synthesis in the skin,
such as quantity and UV light exposure to the skin, the
levels of skin 7-dehydrocholesterol, and skin pigmenta-
tion [52], as well as different dietary levels of dietary
supplementation of vitamin D, affects the immunity and
health status of cattle.
Conclusion
In summary, the present work demonstrates that condi-
tioning of monocytes with the hormone 1,25-(OH)2D3
during the monocyte to DC maturation process induces a
semi-mature or immunotolerant DC phenotype. As a con-
sequence, the antigen presenting capabilities of these cells
is hampered as shown by the reduced ability to endocy-
tose ovalbumin and the inability to induce lymphocyte
proliferation in the context of a mixed leukocyte reaction.
The effects of Vitamin D3-mediated modulation of DC
function (both MoDCs and the recently described bovine
blood DCs [53]) on pathogen-specific T cell responses
should now be investigated, particularly in the context of
diseases such as bovine tuberculosis for which a key role
for Vitamin D3 has been proposed [27].
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